Intraindividual variability of children's blood lipid and lipoprotein concentrations: A review

Preventive Cardiology

Volumn 5, Issue 3, 2002, Pages 145-151

  Tolfrey, Keith ^a  

^a MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHILD; CLINICAL TRIAL; CORRELATION ANALYSIS; EPIDEMIOLOGICAL DATA; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; META ANALYSIS; POPULATION RESEARCH; REVIEW; RISK FACTOR;

EID: 0036626842     PISSN: 1520037X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1520-037X.2002.00563.x     Document Type: Review

References (81)

1. Castelli WP, Garrison RJ, Wilson PW, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: the Framingham Study. JAMA. 1986;256:2835-2838.
2. Pocock J, Shaper AG, Phillips AN, et al. High density lipoprotein cholesterol is not a major risk factor for ischaemic heart disease in British men. BMJ. 1986;292:515-519.
3. Kagan A, McGee DL, Yano K, et al. Serum cholesterol and mortality in a Japanese-American population: the Honolulu Heart Program. Am J Epidemiol. 1981;114:11-20.
4. Kannel WB, Neaton JD, Wentworth D, et al. Overall and coronary heart disease mortality rates in relation to major risk factors in 325,348 men screened for the MRFIT: Multiple Risk Factor Intervention Trial. Am Heart J. 1986;112:825-836.
5. Martin MJ, Hulley SB, Browner WS, et al. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361,662 men. Lancet. 1986;2:933-936.
6. Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings from 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 1986;256:2823-2828.
7. Stamler J. Epidemiology of coronary heart disease. Med Clin North Am. 1973;57:5-46.
8. Bruckner I, Steinbach M. Epidemiology of coronary heart disease. Med Intern. 1975;13:253-260.
9. Keys A. Coronary heart disease - the global picture. Atherosclerosis. 1975;22:149-192.
10. Kannel WB. Some lessons in cardiovascular epidemiology from Framingham. Am J Cardiol. 1976;37:269-282.
11. Castelli WP, Doyle JT, Gordon T. HDL cholesterol and other lipids in coronary heart disease: The Cooperative Lipoprotein Phenotyping Study. Circulation. 1977;55:767-772.
12. Neuman J, de Neumann MP, Valero E, et al. Epidemiology of coronary heart disease risk factors in a free-living population. Prev Med. 1979;8:445-462.
13. Armstrong N, Welsman J. Young People and Physical Activity. Oxford, UK: Oxford University Press; 1997.
14. Newman WP III, Freedman DS, Voors AW, et al. Relation of serum lipoprotein levels and systolic blood pressure to early atherosclerosis. N Engl J Med. 1986;314:138-144.
15. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Natural history of aortic and coronary atherosclerotic lesions in youth: findings from the PDAY Study. Arterioscler Thromb. 1993;13:1291-1298.
16. Cornhill JF, Herderick EE, Vince DG. The clinical morphology of human atherosclerotic lesions: lessons from the PDAY Study. Wien Klin Wochenscher. 1995;107:540-543.
17. Miller GJ, Miller NE. Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease. Lancet. 1975;1:16-19.
18. Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease: the Framingham Study. Am J Med. 1977;62:707-713.
19. Miller NE, Thelle DS, Forde OH, et al. The Tromso Heart Study. High-density lipoprotein and coronary heart-disease: A prospective case-control study. Lancet. 1977;1:965-968.
20. Keys A. Alpha lipoprotein (HDL) cholesterol in the serum and risk of coronary heart disease and death. Lancet. 1980;2:603-606.
21. Miller NE. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J. 1987;113:589-597.
22. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation. 1989;79:8-15.
23. Gordon DJ, Rifkind BM. High-density lipoproteins: The clinical implications of recent studies. N Engl J Med. 1989; 321:1311-1316.
24. Hulley SB, Rosenham RH, Bawol RD et al. Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease. N Engl J Med. 1980; 302:1383-1390.
25. Austin MA. Plasma triglyceride as a risk factor for coronary heart disease, The epidemiologic evidence and beyond. Am J EpidemioL 1989;129:249-259.
26. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of populationbased prospective studies. J Cardiovasc Risk. 1996;3:213-219.
27. Jacobs DR, Barrett-Connor E. Retest reliability of plasma cholesterol and triglyceride. Am J Epidemiol. 1982;116:878-885.
28. Smith SJ, Cooper GR, Myers GL, et al. Biological variability in concentrations of serum lipids: sources of variation among results from published studies and composite predicted values. Clin Chem. 1993;39:1012-1022.
29. Cooper GR, Smith SJ, Myers GL, et al. Estimating and minimizing effects of biological sources of variation by relative range when measuring the mean of serum lipids and lipoproteins. Clin Chem. 1994;40:227-232.
30. Harris EK. Distinguishing physiologic variation from analytic variation. J Chron Dis. 1970;23:469-480.
31. Harris EK, Kanofsky P, Shakarji G, et al. Biological and analytical components of variation in long-term studies of serum constituents in normal subjects. Clin Chem. 1970;16:1022-1027.
32. Pereira MA, Freedson PS, Maliszewski AF. Intraindividual variation during inclined steady-rate treadmill running. Res Q Exerc Sport. 1994;65:184-188.
33. Myers GL, Schap D, Smith SJ, et al. College of American Pathologists: Centers for Disease Control collaborative study for evaluating reference materials for total serum cholesterol measurements. Arch Pathol Lab Med. 1990;114:1199-1205.
34. Demacker PNM, Schade RN, Jansen RT, et al. Intraindividual variation of serum cholesterol, triglycerides, and high-density lipoprotein cholesterol in normal humans. Atherosclerosis. 1982;45:259-266.
35. Cooper GR, Myers GL, Smith SJ, et al. Standardization of lipid, lipoprotein, and apolipoprotein measurements. Clin Chem. 1988;34(suppl):B95-B105.
36. Cooper GR, Myers GL, Smith SJ, et al. Blood lipid measurements: Variation and practical utility. JAMA. 1992;267:1652-1660.
37. Myers GL, Cooper GR, Sampson EJ. Traditional lipoprotein profile: clinical utility, performance requirements, and standardization. Atherosclerosis. 1994;108(suppl):S157-S169.
38. McNamara JR, Leary ET, Ceriotti F, et al. Point: status of lipid and lipoprotein standardization. Clin Chem. 1997; 43:1306-1310.
39. Sniderman AD. Counterpoint: To (measure apo) B or not to (measure apo) B: a critique of modern medical decision-making. Clin Chem. 1997;43:1310-1314.
40. National Cholesterol Education Program (NCEP). Report of the National Cholesterol Education Program Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med. 1988;148:36-69.
41. Bachorik PS, Ross JW. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem. 1995;41:1414-1420.
42. Byers T. Two-test cholesterol screening: computer simulation of a strategy to reduce within-person variance in mass screening programs [abstract]. Am J Epidemiol. 1989;130:853.
43. Weissfeld JL, Weissfeld LA, Holloway JJ, et al. A mathematical representation of the expert panel's guidelines for high blood cholesterol case-finding and treatment. Med Decis Making. 1990;10:135-146.
44. Thompson SG, Pocock SJ. The variability of serum cholesterol measurements: implications for screening and monitoring. J Clin Epidemiol. 1990;43:783-789.
45. Smith M. Taking blood from children causes no more than minimal harm. J Med Ethics. 1985;11:127-131.
46. Lau Y-L, Yeung C-Y. Parental perception of the effect of venepuncture in preschool children in non-therapeutic research. J Paediatr Child Health. 1992;28:294-296.
47. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein in plasma, without the use of preparative ultracentrifuge. Clin Chem. 1972;18:499-502.
48. Warnick GR, Albers JJ. Physiological and analytical variation in cholesterol and triglyceride. Lipids. 1976;11:203-208.
49. Costongs GMPJ, Janson PCW, Bas BM et al. Short-term and long-term intra-individual variations and critical differences of clinical chemical laboratory parameters. J Clin Chem Clin Biochem. 1985;23:7-16.
50. Friedlander Y, Kark JD, Stein Y. Variability of plasma lipids and lipoproteins: the Jerusalem Lipid Research Clinic Study. Clin Chem. 1985;31:1121-1126.
51. Godsland IF. Intra-individual variation: significant changes in parameters of lipid and carbohydrate metabolism in the individual and intra-individual variation in different test populations. Ann Clin Biochem. 1985;22:618-624.
52. Rotterdam EP, Katan MB, Knuiman JT. Importance of time interval between repeated measurements of total or high-density lipoprotein cholesterol when estimating an individual's baseline concentrations. Clin Chem. 1987;33:1913-1915.
53. Ford RP. Essential data derived from biological variation for establishment and use of lipid analyses. Ann Clin Biochem. 1989;26:282-285.
54. Bookstein L, Gidding SS, Donovan M, et al. Day-to-day variability of serum cholesterol, triglyceride, and high-density lipoprotein cholesterol levels. Arch Intern Med. 1990;150:1653-1657.
55. Brown SA, Boerwinkle E, Kashanian FK, et al. Variations in concentrations of lipids, lipoprotein lipids, and apolipoprotein A-1 and B in plasma from healthy women. Clin Chem. 1990;36:207-210.
56. Wasenius A, Stugaard M, Otterstad JE, et al. Diurnal and monthly intra-individual variability of the concentration of lipids, lipoproteins and apoproteins. Scand J Clin Lab Invest. 1990;50:635-642.
57. Irwig L, Glasziou P, Wilson A, et al. Estimating an individual's true cholesterol level and response to intervention. JAMA. 1991;266:1678-1685.
58. Gallagher SK, Johnson LK, Milne DB. Short- and long-term variability of selected indices related to nutritional status. II. Vitamins, lipids, and protein indices. Clin Chem. 1992;38:1449-1453.
59. Kafonek SD, Derby CA, Bachorik PS. Biological variability of lipoproteins and apolipoproteins in patients referred to a lipid clinic. Clin Chem. 1992;38:864-872.
60. Kafonek SD, Donovan L, Lovejoy KL, et al. Biological variation of lipids and lipoproteins in fingerstick blood, Clin Chem. 1996;42:2002-2007.
61. Tolfrey K, Campbell IG, Jones AM. Intra-individual variation of plasma lipids and lipoproteins in prepubescent children. Eur J Appl Physiol. 1999;79:449-456.
62. Guo S, Beckett L, Chumlea WC, et al. Serial analysis of plasma lipids and lipoproteins from individuals 9-21 years of age. Am J Clin Nutr. 1993;58:61-67.
63. Benuck I, Gidding SS, Donovan M. Year-to-year variability of cholesterol levels in a pediatric practice. Arcb Pediatr Adolesc Med. 1995;149:292-296.
64. Krummel D, Etherton TD, Peterson S, et al. Effects of exercise on plasma lipids and lipoproteins of women. Proc Soc Exp Biol Med. 1993;204:123-137.
65. Kim H-K, Kalkhoff RK. Changes in lipoprotein composition during the menstrual cycle. Metabolism. 1979;23:663-668.
66. Jones DY, Judd JT, Taylor PR, et al. Menstrual cycle effect on plasma lipids. Metabolism. 1988;37:1-2.
67. Dwyer T, Coonan WE, Leitch DR, et al. An investigation of the effects of daily physical activity on the health of primary school students in South Australia. Int J Epidemiol. 1983;12:308-313.
68. Linder CW, DuRant RH, Mahoney OM. The effect of physical conditioning on serum lipids and lipoproteins in white male adolescents. Med Sci Sports Exerc. 1983;15:232-236.
69. Haskell WL. The influence of exercise on the concentrations of triglyceride and cholesterol in human plasma. Exerc Sport Sci Rev. 1984;12:205-244.
70. Savage MP, Petratis MM, Thomson WH, et al. Exercise training effects on serum lipids of prepubescent boys and adult men. Med Sci Sports Exerc. 1986;18:197-204.
71. Ben-Ezra V, Gallagher K. Blood lipid profiles of 8-10 year old children: the effect of diet and exercise [abstract]. Med Sci Sports Exerc. 1989;21:584.
72. 2, body composition and blood lipids in 7 to 9 year old children. Int J Sports Med. 1980;1:73-78.
73. Tolfrey K, Campbell IG, Batterham AM. Exercise training induced alterations in prepubertal children's lipid-lipoprotein profile. Med Sci Sports Exerc. 1998;30:1684-1692.
74. Morrison JA, Laskarzewski P, deGroot I, et al. Diagnostic ramifications of repeated plasma cholesterol and triglyceride measurements in children: regression toward the mean in a pediatric population. Pediatrics. 1979;64:197-201.
75. Bland M. An Introduction to Medical Statistics. Oxford, UK: Oxford University Press; 1995.
76. Elveback LR, Weidman WH, Ellefson RD. Day-to-day variability and analytic error in determination of lipids in children. Mayo Clin Proc. 1980;55:267-269.
77. Gillman MW, Cupples LA, Moore LL, et al. Impact of within-person variability on identifying children with hypercholesterolemia: Framingham children's study. J Pediatr. 1992;121:342-347.
78. Marks DB, Marks AD, Smith CM. Basic Medical Biochemistry. Baltimore, MD: Williams and Wilkins; 1996.
79. Blessing DL, Keith RE, Williford HN, et al. Blood lipid and physiological responses to endurance training in adolescents. Pediatr Exerc Sci. 1995;7:192-202.
80. Rowland TW. Developmental Exercise Physiology. Champaign, IL: Human Kinetics; 1996.
81. Freedman DS, Byers T, Sell K, et al. Tracking of serum cholesterol levels in a multiracial sample of preschool children. Pediatrics. 1992;90:80-86.